Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

Duchesnay Inc. v. Pharmascience Inc. and the Minister of Health - doxylamine / pyridoxine NOC proceedings

Fasken
Reading Time 1 minute read
Proceedings to prohibit the Minister of Health from issuing a notice of compliance which would allow the sale by Pharmascience of a generic version of Diclectin, a combination of doxylamine succinate and pyridoxine hydrochloride used for the treatment of nausea and vomiting of pregnancy, until the expiry of Canadian patent no 2,350,195. The patent at issue covers a formulation of doxylamine and pyridoxine, together with a disintegrating agent, in a capsule covered by an enteric coating which satisfies particular dissolution profiles. Pharmascience consented to a prohibition order. Duchesnay was advised in these proceedings by a team from Fasken Martineau that included Marie Lafleur and Julie Desrosiers. See Court file